FMT Literature
Other: Intestinal Microbiota Transplantation
Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian, China
https://clinicaltrials.gov/show/NCT03426683
Biological: Fecal Microbiota Transplantation (FMT)
Children's Mercy Hospital, Kansas City, Missouri, United States
https://clinicaltrials.gov/show/NCT02108821
Dietary Supplement: Feces
Helse Fonna, Haugesund, Norway
https://clinicaltrials.gov/show/NCT04236843
Biological: Fecal microbiota transplantation (FMT)
Ã…lesund Hospital, Ã…lesund, Norway
https://clinicaltrials.gov/show/NCT04691544
Dietary Supplement: Anaerobically Cultivated Human Intestinal Microbiota (ACHIM)|Dietary Supplement: Donor fecal microbiota transplantation|Dietary Supplement: Placebo
Haukeland Unversity Hospital, Bergen, Norway
https://clinicaltrials.gov/show/NCT05088434
Procedure: FMT|Drug: Mesalazine
Department of Gastroenterology, Research Institute of Surgery, Da ping Hospital, The Third Military Medical University, Chongqing, Chongqing, China
https://clinicaltrials.gov/show/NCT02335281
Procedure: FMT with donor stool|Procedure: FMT with own stool
Ghent University Hospital, Ghent, Belgium
https://clinicaltrials.gov/show/NCT02299973
Drug: Fecal microbiota transplantation capsules|Drug: Placebo capsules
Medical Research Center of Connecticut, Hamden, Connecticut, United States|Montefiore Medical Center, Bronx, New York, United States|Concorde Medical Group, New York, New York, United States
https://clinicaltrials.gov/show/NCT02328547
Procedure: fecal microbiota transplantation|Drug: placebo fecal microbiota transplantation|Procedure: FMT with antibiotic pre-treatment (v1)|Procedure: FMT with antibiotic pre-treatment (v2)
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
https://clinicaltrials.gov/show/NCT02847481
Biological: Fecal Microbiota Transplant (FMT)|Biological: Placebo
Boston Children's Hospital, Boston, Massachusetts, United States
https://clinicaltrials.gov/show/NCT02330653
Procedure: fecal microbiota transplantation|Procedure: Infusion of sham|Drug: probiotics, antibiotics or antidepressants
Guangzhou First People's Hospital, Guangzhou, Guangdong, China
https://clinicaltrials.gov/show/NCT03613545
Biological: FMT
Helsinki University Hospital, Helsinki, Helsinki And Uusimaa, Finland
https://clinicaltrials.gov/show/NCT05361785
FMT Reference
  1. American Society for Microbiology. (2024, February 9). Fecal microbiota transplants (FMT): Past, present and future. ASM.org. https://asm.org/articles/2024/february/fecal-microbiota-transplants-past-present-futureBethlehem, L., Estevinho, M. M., Grinspan, A., Magro, F., Faith, J. J., &
  2. Colombel, J. (2024). Microbiota therapeutics for inflammatory bowel disease: The way forward. The Lancet Gastroenterology & Hepatology, 9(5), 476-486. https://doi.org/10.1016/s2468-1253(23)00441-7Feng, J., Chen, Y., Liu, Y., Lin, L., Lin, X., Gong, W., Xia, R., He, J., Sheng, J., Cai, H., & Xiao, C. (2023).
  3. Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: A systematic review and meta-analysis. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-41182-6Goldenberg, D., & Melmed, G. Y. (2023).
  4. Fecal transplant: The benefits and harms of fecal microbiota transplantation. Clinical Understanding of the Human Gut Microbiome, 129-140. https://doi.org/10.1007/978-3-031-46712-7_9Karimi, M., Hashempour, Z., Hirsalimi, N., Salehi Omran, H., Sedighi, E., Beigi, F., & Mortezazadeh, M. (2024).
  5. Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review. Front Immunol, 15(1439176). https://doi.org/10.3389/fimmu.2024.1439176Rai, S. (2024).
  6. Fecal microbiota transplantation: A comprehensive review. Era's Journal of Medical Research, 11(1), 71-75. https://doi.org/10.24041/ejmr2024.12Serrano-Villar, S., Talavera-Rodríguez, A., Gosalbes, M.J. et al. Fecal microbiota transplantation in HIV: A pilot placebo-controlled study. Nat Commun 12, 1139 (2021). https://doi.org/10.1038/s41467-021-21472-1